Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages

Nature Metabolism volume 5, pages 804–820 (2023)Cite this article

Subjects

Abstract

Glycolysis is essential for the classical activation of macrophages (M1), but how glycolytic pathway metabolites engage in this process remains to be elucidated. Glycolysis leads to production of pyruvate, which can be transported into the mitochondria by the mitochondrial pyruvate carrier (MPC) followed by utilization in the tricarboxylic acid cycle. Based on studies that used the MPC inhibitor UK5099, the mitochondrial route has been considered to be of significance for M1 activation. Using genetic approaches, here we show that the MPC is dispensable for metabolic reprogramming and activation of M1 macrophages. In addition, MPC depletion in myeloid cells has no impact on inflammatory responses and macrophage polarization toward the M1 phenotype in a mouse model of endotoxemia. While UK5099 reaches maximal MPC inhibitory capacity at approximately 2–5 μM, higher concentrations are required to inhibit inflammatory cytokine production in M1 and this is independent of MPC expression. Taken together, MPC-mediated metabolism is dispensable for the classical activation of macrophages and UK5099 inhibits inflammatory responses in M1 macrophages due to effects other than MPC inhibition.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: UK5099-suppressed inflammatory cytokine production is concentration dependent.
Fig. 2: UK5099 suppresses oxidative phosphorylation, mitochondrial membrane potential as well as HIF-1α stabilization and its regulation of gene expression.
Fig. 3: UK5099 suppresses inflammatory responses independently of MPC expression.
Fig. 4: Off-target effects of UK5099 on cellular metabolism and HIF-1α stabilization.
Fig. 5: Mpc depletion reduces glucose fuel into the TCA cycle.
Fig. 6: The impacts of Mpc depletion on metabolic reprogramming in LPS-stimulated macrophages.
Fig. 7: Mpc depletion is dispensable for proinflammatory cytokine production in LPS-stimulated macrophages.
Fig. 8: Mpc is not required for inflammatory responses in vivo.

Similar content being viewed by others

Data availability

The raw sequence data reported in this paper have been deposited in the Genome Sequence Archive (GSA) in the National Genomics Data Center, China National Center for Bioinformation/Beijing Institute of Genomics, Chinese Academy of Sciences, under accession code GSA: CRA009169 (RNA-seq data) and GSA: CRA009183 (single-cell RNA-seq data), which are publicly accessible at https://ngdc.cncb.ac.cn/gsa (refs. 49,50). Other data that support the findings of this study are available from the corresponding authors upon reasonable request. Source data are provided with this paper.

References

  1. O’Neill, L. A., Kishton, R. J. & Rathmell, J. A guide to immunometabolism for immunologists. Nat. Rev. Immunol. 16, 553 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Wang, A., Luan, H. H. & Medzhitov, R. An evolutionary perspective on immunometabolism. Science 363, eaar3932 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. Van den Bossche, J., O’Neill, L. A. & Menon, D. Macrophage immunometabolism: where are we (going)? Trends Immunol. 38, 395–406 (2017).

    Article  PubMed  Google Scholar 

  4. Russell, D. G., Huang, L. & VanderVen, B. C. Immunometabolism at the interface between macrophages and pathogens. Nat. Rev. Immunol. 19, 291–304 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Ryan, D. G. & O’Neill, L. A. Krebs cycle reborn in macrophage immunometabolism. Annu. Rev. Immunol. 38, 289–313 (2020).

    Article  PubMed  CAS  Google Scholar 

  6. Tannahill, G. M. et al. Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature 496, 238–242 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  7. Mills, E. L. et al. Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages. Cell 167, 457–470 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  8. Bricker, D. K. et al. A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humans. Science 337, 96–100 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Herzig, S. et al. Identification and functional expression of the mitochondrial pyruvate carrier. Science 337, 93–96 (2012).

    Article  PubMed  CAS  Google Scholar 

  10. Lauterbach, M. A. et al. Toll-like receptor signaling rewires macrophage metabolism and promotes histone acetylation via ATP-citrate lyase. Immunity 51, 997–1011 (2019).

    Article  PubMed  CAS  Google Scholar 

  11. Langston, P. K. et al. Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses. Nat. Immunol. 20, 1186–1195 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Meiser, J. et al. Pro-inflammatory macrophages sustain pyruvate oxidation through pyruvate dehydrogenase for the synthesis of itaconate and to enable cytokine expression. J. Biol. Chem. 291, 3932–3946 (2016).

    Article  PubMed  CAS  Google Scholar 

  13. Bae, S. et al. MYC-mediated early glycolysis negatively regulates proinflammatory responses by controlling IRF4 in inflammatory macrophages. Cell Rep. 35, 109264 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  14. Martínez-Reyes, I. et al. TCA cycle and mitochondrial membrane potential are necessary for diverse biological functions. Mol. Cell 61, 199–209 (2016).

    Article  PubMed  Google Scholar 

  15. Hill, B. G. et al. Integration of cellular bioenergetics with mitochondrial quality control and autophagy. Biol. Chem. 393, 1485–1512 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  16. Chua, Y. L. et al. Stabilization of hypoxia-inducible factor-1α protein in hypoxia occurs independently of mitochondrial reactive oxygen species production. J. Biol. Chem. 285, 31277–31284 (2010).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Agani, F. H., Pichiule, P., Chavez, J. C. & LaManna, J. C. Inhibitors of mitochondrial complex I attenuate the accumulation of hypoxia-inducible factor-1 during hypoxia in Hep3B cells. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 132, 107–109 (2002).

    Article  PubMed  Google Scholar 

  18. Cramer, T. et al. HIF-1α is essential for myeloid cell-mediated inflammation. Cell 112, 645–657 (2003).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  19. Ke, Q. & Costa, M. Hypoxia-inducible factor-1 (HIF-1). Mol. Pharmacol. 70, 1469–1480 (2006).

    Article  PubMed  CAS  Google Scholar 

  20. McCommis, K. S. et al. Loss of mitochondrial pyruvate carrier 2 in the liver leads to defects in gluconeogenesis and compensation via pyruvate-alanine cycling. Cell Metab. 22, 682–694 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Shi, J., Hua, L., Harmer, D., Li, P. & Ren, G. Cre driver mice targeting macrophages. Methods Mol. Biol. 1784, 263–275 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Zhang, X., Goncalves, R. & Mosser, D. M. The isolation and characterization of murine macrophages. Curr. Protoc. Immunol. 83, 14–1 (2008).

    Google Scholar 

  23. Wang, F. et al. Interferon-γ induces reversible metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity. eBioMedicine 30, 303–316 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  24. Wang, F. et al. Glycolytic stimulation is not a requirement for M2 macrophage differentiation. Cell Metab. 28, 463–475 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  25. Witsell, A. L. & Schook, L. B. Macrophage heterogeneity occurs through a developmental mechanism. Proc. Natl Acad. Sci. USA 88, 1963–1967 (1991).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  26. Divakaruni, A. S., Paradyse, A., Ferrick, D. A., Murphy, A. N. & Jastroch, M. Analysis and interpretation of microplate-based oxygen consumption and pH data. Methods Enzymol. 547, 309–354 (2014).

    Article  PubMed  CAS  Google Scholar 

  27. Vigueira, P. A. et al. Mitochondrial pyruvate carrier 2 hypomorphism in mice leads to defects in glucose-stimulated insulin secretion. Cell Rep. 7, 2042–2053 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Divakaruni, A. S. et al. Thiazolidinediones are acute, specific inhibitors of the mitochondrial pyruvate carrier. Proc. Natl Acad. Sci. USA 110, 5422–5427 (2013).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  29. Divakaruni, A. S. et al. Etomoxir inhibits macrophage polarization by disrupting CoA homeostasis. Cell Metab. 28, 490–503 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  30. Zhang, H. N. et al. Systematic identification of arsenic-binding proteins reveals that hexokinase-2 is inhibited by arsenic. Proc. Natl Acad. Sci. USA 112, 15084–15089 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  31. Colegio, O. R. et al. Functional polarization of tumour-associated macrophages by tumour-derived lactic acid. Nature 513, 559–563 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  32. Noe, J. T. et al. Lactate supports a metabolic-epigenetic link in macrophage polarization. Sci. Adv. 7, eabi8602 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Lagziel, S., Gottlieb, E. & Shlomi, T. Mind your media. Nat. Metab. 2, 1369–1372 (2020).

    Article  PubMed  Google Scholar 

  34. Gautier, E. L. et al. Gata6 regulates aspartoacylase expression in resident peritoneal macrophages and controls their survival. J. Exp. Med. 211, 1525–1531 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Rodriguez, A. E. et al. Serine metabolism supports macrophage IL-1β production. Cell Metab. 29, 1003–1011 (2019).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  36. Baardman, J. et al. A defective pentose phosphate pathway reduces inflammatory macrophage responses during hypercholesterolemia. Cell Rep. 25, 2044–2052 (2018).

    Article  PubMed  CAS  Google Scholar 

  37. Baardman, J. et al. Macrophage ATP citrate lyase deficiency stabilizes atherosclerotic plaques. Nat. Commun. 11, 1–15 (2020).

    Article  Google Scholar 

  38. Verberk, S. G. et al. Myeloid ATP citrate lyase regulates macrophage inflammatory responses in vitro without altering inflammatory disease outcomes. Front. Immunol. 12, 669920 (2021).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  39. Wang, Y. et al. Improvement of obesity-associated disorders by a small-molecule drug targeting mitochondria of adipose tissue macrophages. Nat. Commun. 12, 1–16 (2021).

    Google Scholar 

  40. Liu, X. et al. Acetate production from glucose and coupling to mitochondrial metabolism in mammals. Cell 175, 502–513 (2018).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  41. Bensard, C. L. et al. Regulation of tumor initiation by the mitochondrial pyruvate carrier. Cell Metab. 31, 284–300 (2020).

    Article  PubMed  CAS  Google Scholar 

  42. Vacanti, N. M. et al. Regulation of substrate utilization by the mitochondrial pyruvate carrier. Mol. Cell 56, 425–435 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Bender, T., Pena, G. & Martinou, J. C. Regulation of mitochondrial pyruvate uptake by alternative pyruvate carrier complexes. EMBO J. 34, 911–924 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  44. Schell, J. C. & Rutter, J. The long and winding road to the mitochondrial pyruvate carrier. Cancer Metab. 1, 1–9 (2013).

    Article  Google Scholar 

  45. Proudlove, M. O., Beechey, R. B. & Moore, A. L. Pyruvate transport by thermogenic-tissue mitochondria. Biochem. J. 247, 441–447 (1987).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  46. Halestrap, A. P. The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem. J. 148, 85–96 (1975).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  47. Lee, W. N., Byerley, L. O., Bergner, E. A. & Edmond, J. Mass isotopomer analysis: theoretical and practical considerations. Biol. Mass Spectrom. 20, 451–458 (1991).

    Article  PubMed  CAS  Google Scholar 

  48. Satija, R., Farrell, J. A., Gennert, D., Schier, A. F. & Regev, A. Spatial reconstruction of single-cell gene expression data. Nat. Biotechnol. 33, 495–502 (2015).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  49. Chen, T. et al. The Genome Sequence Archive family: toward explosive data growth and diverse data types. Genom. Proteom. Bioinform. 19, 578–583 (2021).

    Article  Google Scholar 

  50. CNCB-NGDC Members and Partners. Database Resources of the National Genomics Data Center, China National Center for Bioinformation in 2022. Nucleic Acids Res. 50, D27–D38 (2022).

    Article  Google Scholar 

Download references

Acknowledgements

This study was supported by the National Natural Science Foundation of China (grant nos. 81970073 and 82170090 to F.W.), the Shanghai Science and Technology Commission (grant nos. 19ZR1441600 and 21Y11901100 to F.W.), the Shanghai Pujiang Program (grant no. 2020PJD051 to F.W.), the Outstanding Clinical Discipline Project of Shanghai Pudong, the Top-level Clinical Discipline Project of Shanghai Pudong (grant no. PWYgf2021-05 to Q.L.) and the Academic Leaders Training Program of Pudong Health and Family Planning Commission of Shanghai (grant no. PWRd2019-02 to F.W.).

Author information

Author notes

  1. These authors contributed equally: Linyu Ran, Song Zhang.

Authors and Affiliations

  1. Department of Pulmonary and Critical Care Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China

    Linyu Ran, Guosheng Wang, Pei Zhao, Jiaxing Sun, Qiang Li & Feilong Wang

  2. Medical College, Tongji University, Shanghai, China

    Linyu Ran & Pei Zhao

  3. Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN, USA

    Song Zhang, Ryounghoon Jeon & Joerg Herrmann

  4. Center for Regenerative Medicine, Mayo Clinic, Rochester, MN, USA

    Song Zhang & Ryounghoon Jeon

  5. Shenzhen Key Laboratory of Synthetic Genomics, Guangdong Provincial Key Laboratory of Synthetic Genomics, CAS Key Laboratory of Quantitative Engineering Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China

    Jiaqi Zhou & Haiyun Gan

  6. Preclinical Research Center, Daegu-Gyeongbuk Medical Innovation Foundation (KMEDIhub), Daegu, Republic of Korea

    Ryounghoon Jeon

Authors
  1. Linyu Ran
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Song Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Guosheng Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Pei Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jiaxing Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Jiaqi Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Haiyun Gan
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Ryounghoon Jeon
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Qiang Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Joerg Herrmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Feilong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceptualization was the responsibility of F.W. and S.Z. Methodology was the responsibility of F.W., S.Z., R.J., J.Z., H.G. and J.H. Validation was the responsibility of F.W. and S.Z. Investigation was the responsibility of L.R., S.Z., G.W. and P.Z. Writing of the original draft was carried out by F.W. and J.H. Review and editing was carried out by F.W., S.Z., Q.L. and J.H. Supervision was the responsibility of F.W., Q.L. and J.H. Funding acquisition was the responsibility of F.W., Q.L. and J.H.

Corresponding authors

Correspondence to Joerg Herrmann or Feilong Wang.

Ethics declarations

Competing interests

The authors declare no competing interests.

Peer review

Peer review information

Nature Metabolism thanks Jan Van den Bossche, Laurent Yvan-Charvet and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Primary Handling Editor: Alfredo Giménez-Cassina, in collaboration with the Nature Metabolism team.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Extended data

Extended Data Fig. 1 Conditional knock-out of Mpc1 in myeloid cells.

(a) Cell viability of WT BMDMs after 24 hours stimulation with LPS ± 1 hour pre-treatment with different concentrations of UK5099 (n = 6 biologically independent samples). (b) Gene targeting strategy for Mpc1 depletion in exon 3–5 in a Lyz2-conditional manner. (c) and (d) Expression of Mpc1 and Mpc2 mRNA in Mpc1fl/fl and Mpc1ΔLysM BMDMs (n = 4 biologically independent samples). (e) and (f) Expression of MPC1 and MPC2 protein in Mpc1fl/fl and Mpc1ΔLysM BMDMs. (g) and (h) Expression of Mpc1 and Mpc2 mRNA in Mpc1fl/fl and Mpc1ΔLysM AMs (n = 3 mice). (i) Cell viability of Mpc1fl/fl and Mpc1ΔLysM BMDMs after 24 hours stimulation with LPS ± 1 hour pre-treatment with 100 μM UK5099 (n = 8 biologically independent samples). Data are representative of three independent experiments (a, g, h, i). Data are representative of at least ten independent experiments (c to f). P values were calculated using one-way ANOVA with Fisher’s LSD post hoc analysis (a) or unpaired, two-sided Student’s t-test (c, d, g, h, i). Data are presented as mean ± s.e.m.

Source data

Extended Data Fig. 2 UK5099 suppresses macrophages activation independent of MPC expression in LPS-stimulated macrophages.

(a) Volcano plots of gene expression in Mpc1fl/fl and Mpc1ΔLysM BMDMs with or without pre-treatment with 100 μM UK5099 (Related to Figure 3g–i). (b) Venn diagrams showing overlap of UK5099 (100 μM)-altered genes between Mpc1fl/fl and Mpc1ΔLysM BMDMs with (down panel) or without (up panel) LPS stimulation. (c) Heat map of gene expression in Mpc1fl/fl and Mpc1ΔLysM BMDMs after 4 hours stimulation with LPS ± 1 hour pre-treatment with UK5099 (100 μM). The included genes were those significantly changed by UK5099 treatment in both Mpc1fl/fl and Mpc1ΔLysM BMDMs with or without LPS stimulation (Fold change˃1.5 & q-value˂0.05). (d) Flow cytometry analysis of F4/80 and CD11b expression in BMDMs. (e) UMAP clustering of scRNA-seq from Mpc1fl/fl and Mpc1ΔLysM BMDMs after 4 hours stimulation with LPS ± 1 hour pre-treatment with 100 μM UK5099. (f) UMAP plots of Adgre 1 (F4/80), Itgam (CD11b) and Lyz2 (LysM) expression among pooled samples. (g) Heat map of HIF-1α targeted gene expression of Mpc1fl/fl and Mpc1ΔLysM BMDMs after 4 hours stimulation with LPS ± 1 hour pre-treatment with 100 μM UK5099. (h) Heat map of oxidoreductase activity (GO:0016712) Gene Set in LPS-stimulated Mpc1fl/fl (left panel) and Mpc1ΔLysM (right panel) BMDMs with and without 100 μM UK5099 pre-treatment (Related to Fig. 4q). Data are representative of three independent experiments (d).

Extended Data Fig. 3 Mpc1 depletion reduces pyruvate fueling of the TCA cycle in LPS-stimulated macrophages.

(a) to (e) U-[13C]-Pyruvate labeled TCA cycle metabolites in Mpc1fl/fl and Mpc1ΔLysM BMDMs with or without stimulation by LPS for 2 hours (n = 4 biologically independent samples). (f) to (j) U-[13C]-Pyruvate labeled TCA cycle metabolites m+3 fraction in Mpc1fl/fl and Mpc1ΔLysM BMDMs with or without stimulation by LPS for 2 hours (n = 4 biologically independent samples). Data are representative of two independent experiments (a to j). P values were calculated by two-way ANOVA with Fisher’s LSD post hoc analysis. Data are presented as mean ± s.e.m.

Extended Data Fig. 4 Acute loss of Mpc1 has no impact on proinflammatory cytokines production in LPS-stimulated macrophages.

(a) to (b) Expression of Mpc1 and Mpc2 mRNA in Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs treated with 4-Hydroxytamoxifen for 3 days (n = 3 biologically independent samples). (c) Expression of MPC1 and MPC2 protein in Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs treated with 4-Hydroxytamoxifen for 3 days. (d) to (f) Expression of proinflammatory cytokines mRNA in Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs with or without stimulation by LPS for 4 hours (n = 3 biologically independent samples). (g) to (i) Proinflammatory cytokines secretion of Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs with or without stimulation by LPS for 24 hours (n = 4 biologically independent samples). (j) to (l) Expression of proinflammatory cytokines mRNA in Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs after 4 hours stimulation with LPS ± 1 hour pre-treatment with 100 μM UK5099 (n = 3 biologically independent samples). (m) to (o) Proinflammatory cytokines secretion by Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs after 24 hours stimulation with LPS ± 1 hour pre-treatment with 100 μM UK5099 (n = 4 biologically independent samples). (p) Immunoblot analysis of histone acetylation (H3K9) in Mpc1fl/fl and Mpc1ΔLysM-ERT BMDMs with or without stimulation by LPS for the indicated times. Data are representative of at least five independent experiments (a to c, p). Data are representative of four independent experiments (d to i). Data are representative of three independent experiments (j to o). P values were calculated by two-way ANOVA with Fisher’s LSD post hoc analysis (a, b) or unpaired, two-sided Student’s t-test (d to o). Data are presented as mean ± s.e.m.

Source data

Extended Data Fig. 5 Mpc1 depletion reduces lactate fueling of the TCA cycle.

(a) to (d) U-[13C]-Lactate labeled TCA cycle metabolites in Mpc1fl/fl and Mpc1ΔLysM BMDMs (n = 5 biologically independent samples). (e) Gating strategy for peritoneal macrophages.Data are representative of two independent experiments (a to d). P values were calculated using unpaired, two-sided Student’s t-test. Data are presented as mean ± s.e.m.

Extended Data Table 1 UK5099-binding proteins by proteome microarray assays
Full size table
Extended Data Table 2 List of primer sequences used for gene expression analysis
Full size table

Supplementary information

Source data

Source Data Fig. 1

Unprocessed and uncropped images of western blots. RAW images of Fig. 1n.

Source Data Fig. 2

Unprocessed and uncropped images of western blots. RAW images of Fig. 2e.

Source Data Fig. 4

Unprocessed and uncropped images of western blots. RAW images of Fig. 4o.

Source Data Fig. 7

Unprocessed and uncropped images of western blots. RAW images of Fig. 7g,j,m.

Source Data Extended Data Fig. 1

Unprocessed and uncropped images of western blots. RAW images of Extended Data Fig. 1e,f.

Source Data Extended Data Fig. 4

Unprocessed and uncropped images of western blots. RAW images Extended Data Fig. 4c,p.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ran, L., Zhang, S., Wang, G. et al. Mitochondrial pyruvate carrier-mediated metabolism is dispensable for the classical activation of macrophages. Nat Metab 5, 804–820 (2023). https://doi.org/10.1038/s42255-023-00800-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s42255-023-00800-3

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research